R. Fleischmann

发表论文 43 篇 · 总被引 3398 次 · h-index 15

代表论文

Efficacy and safety of JAK inhibitors in rheumatoid arthritis: update for the practising clinician (2024 · Nature Reviews Rheumatology · 被引 137)
TYK2: an emerging therapeutic target in rheumatic disease (2024 · Nature Reviews Rheumatology · 被引 57)
A comparative clinical study of PF-06410293, a candidate adalimumab biosimilar, and adalimumab reference product (Humira®) in the treatment of active rheumatoid arthritis (2018 · Arthritis Research & Therapy · 被引 50)
Risk of Venous Thromboembolism With Tofacitinib Versus Tumor Necrosis Factor Inhibitors in Cardiovascular Risk‐Enriched Rheumatoid Arthritis Patients (2024 · Arthritis & Rheumatology · 被引 32)
Long-term safety and efficacy of upadacitinib versus adalimumab in patients with rheumatoid arthritis: 5-year data from the phase 3, randomised SELECT-COMPARE study (2024 · RMD Open · 被引 28)
Repository Corticotropin Injection for Active Rheumatoid Arthritis Despite Aggressive Treatment: A Randomized Controlled Withdrawal Trial (2020 · Rheumatology and Therapy · 被引 21)